Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Rüdiger Hehlmann

Long-Term Survival With CML With Imatinib or Transplantation as First-Line Treatment: Comparison of Outcomes From CML Studies IIIA and IV

Cellular Therapy and Transplantation

Transplantation

Molecular Medicine

2017

English

Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study

English

Related publications

CML: Langzeitresultate Zum Imatinib-Stopp

Im Focus Onkologie

2017

English

Prognostic Factors for Outcomes in Allogeneic Transplantation for CML in the Imatinib Era: A CIBMTR Analysis

Bone Marrow Transplantation

Transplantation

Hematology

2011

English

CXCR4 Up-Regulation by Imatinib Induces Chronic Myelogenous Leukemia (CML) Cell Migration to Bone Marrow Stroma and Promotes Survival of Quiescent CML Cells

Molecular Cancer Therapeutics

Cancer Research

Oncology

2008

English

Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation

English

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

English

Duplication of Isoderivative Ph Chromosome With Tp53 Deletion in a Case of Imatinib Resistant CML

International Journal of Human Genetics

Genetics

2019

English

Downregulation of Γ-Catenin Inhibits CML Cell Growth and Potentiates the Response of CML Cells to Imatinib Through Β-Catenin Inhibition

International Journal of Molecular Medicine

Medicine

Genetics

2012

English

P3.13-10 Factors Associated With Long-Term Survival of Stage IV NSCLC Patients on First-Line EGFR-Targeting Therapy

Journal of Thoracic Oncology

English

Comparison of Total Body Irradiation vs Busulfan in Combination With Cyclophosphamide as Conditioning for Unrelated Stem Cell Transplantation in CML Patients

Bone Marrow Transplantation

Transplantation

Hematology

2001

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Rüdiger Hehlmann

Long-Term Survival With CML With Imatinib or Transplantation as First-Line Treatment: Comparison of Outcomes From CML Studies IIIA and IV

Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study

Related publications

CML: Langzeitresultate Zum Imatinib-Stopp

Prognostic Factors for Outcomes in Allogeneic Transplantation for CML in the Imatinib Era: A CIBMTR Analysis

CXCR4 Up-Regulation by Imatinib Induces Chronic Myelogenous Leukemia (CML) Cell Migration to Bone Marrow Stroma and Promotes Survival of Quiescent CML Cells

Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

Duplication of Isoderivative Ph Chromosome With Tp53 Deletion in a Case of Imatinib Resistant CML

Downregulation of Γ-Catenin Inhibits CML Cell Growth and Potentiates the Response of CML Cells to Imatinib Through Β-Catenin Inhibition

P3.13-10 Factors Associated With Long-Term Survival of Stage IV NSCLC Patients on First-Line EGFR-Targeting Therapy

Comparison of Total Body Irradiation vs Busulfan in Combination With Cyclophosphamide as Conditioning for Unrelated Stem Cell Transplantation in CML Patients